FUNDS - Cancer Charity Support Fund Moderate
Last update on: 30/09/2014

Fundname
Cancer Charity Support Fund Moderate

Investment trust
PMG Fonds Management AG

Fund data (Balanced Fund)

   
Fund size

(as of 30/09/2014)

21.76 mil. CHF
ISIN CH0102924906
Fund price (as of 30/09/2014)
Offer n.s.
Bid 105.90 Schweizer Franken

* in relation to accumulation unit

Growth (as of 30/09/2014) *

   
5 Years 32.13 %
3 Years 14.84 %
1 Year 1.37 %
Current year 4.42 %
Benchmark n.s.

* in Euro (€)

Master data
ISIN CH0102924906
Launch date 31/07/2009
Available in CH
Fund type Balanced Fund
Kind of fund Other funds / Donation fund
Aim of investment The objective of this fund is primarily to achieve adequate long-term income and capital growth in the unit of account.
Investment strategy The investment focus is determined situationally. The investments can focus on a few asset classes. For investments in equities a focus is set to companies that are in the field of cancer research and cancer control work and / or have a sustainable business.
Investment process So fewer people fall ill with cancer and more people survive cancer, "this is the credo of the Cancer charity Support Fund, that offers investors the opportunity to invest and donate with a single transaction. 50% of the return is given as a donation to the the non-profit institutions Cancer Society and Cancer Research Switzerland for their achievements in the fight against cancer especially cancer research.

The CCSF Moderate investes broadly diversified across all asset classes. The equity portion is invested in companies with sustainable business policies and in companies that are active in the fight against cancer. These forward-looking long-term investments promise attractive returns while supporting the goals and values of the initiators Cancer League Switzerland and Cancer Research Switzerland in an innovative way.
Positive criteria n.s.
Excluding criteria n.s.
Research done by InHouse
 

 

Newsletter

Please enter your email address to get the latest news: